top of page

Contribute to the

Healthcare Dialogue

EXECUTIVE THOUGHT LEADERSHIP & CONTRIBUTOR INSIGHTS

Submit An Article

Healthcare Insights welcomes rigorous review and analysis from journalists, clinicians, and industry strategists, as well as authentic, high-impact perspectives from healthcare executives, business leaders, and industry professionals at the forefront of healthcare innovation.
 
We maintain a selective editorial desk to ensure our readership only receives the highest caliber of insight. Due to our limited seasonal capacity and commitment to thorough editorial review, we prioritize evergreen pieces that offer unique data or unconventional perspectives on market shifts, sector trends, or exclusive insights..

All external contributions must undergo a formal editorial review process. Below are our guidelines and the process for moving forward.

If you would like to move forward with the guest contribution process, please reach out to us directly at editor@healthcarein.org with Subject Line: "Guest Contribution". Please include the author's full name, best email address, article category, and proposed article draft with an executive summary. If we are interested in moving forward with your piece, we will let you know of our terms, policies, and standard editorial fees that apply to all features.

Please direct all inquiries regarding Guest Contributions to:
editor@healthcarein.org.

Article Category

A: Industry Perspectives
- [1200 - 2400] Word Count

B: Deep-Dive/Analysis
- [1500 - 4800] Word Count


C: White Paper/Report with Executive Summary (PDF)
- [4000+] Word Count


Each article category will meet a different word count and style, and incur a different standard editorial fee. All pieces submitted by a PR firm or agency will incur an additional fee.

Covering the Latest
in Healthcare & Business

OUR LATEST INSIGHTS

What policymakers frame as a cost-saving measure will be felt by scientists working on life-saving discoveries and patients who desperately need them.

“It has become clear that truth and transparency are not desired by the secretary [RFK Jr.]”, C.B.E.R. Director Peter Marks wrote in a letter to the FDA.

The new role shoulders the weight of overseeing both Medicare and Medicaid, programs that provide essential health coverage to millions of Americans. 

image.png
image.png
image.png

NEWSLETTER

Stay in the loop.

bottom of page